Integer Holdings Corporation (NYSE:ITGR – Get Free Report) has been given an average recommendation of “Hold” by the fourteen research firms that are presently covering the firm, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $109.8571.
Several equities analysts have issued reports on ITGR shares. Citigroup lifted their price target on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. KeyCorp cut Integer from an “overweight” rating to a “sector weight” rating in a research report on Monday, August 3rd. Freedom Capital cut Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a research report on Monday, September 14th. Finally, Zacks Research upgraded Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th.
Check Out Our Latest Stock Analysis on ITGR
Insider Activity at Integer
Hedge Funds Weigh In On Integer
Hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP lifted its position in Integer by 6.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,484,396 shares of the medical equipment provider’s stock worth $130,620,000 after acquiring an additional 90,277 shares during the period. Irenic Capital Management LP acquired a new position in shares of Integer in the fourth quarter valued at about $99,109,000. Geode Capital Management LLC increased its holdings in shares of Integer by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 832,911 shares of the medical equipment provider’s stock valued at $65,336,000 after purchasing an additional 3,664 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Integer by 1,141.6% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 819,046 shares of the medical equipment provider’s stock worth $72,076,000 after purchasing an additional 753,081 shares during the last quarter. Finally, Cooke & Bieler LP raised its stake in shares of Integer by 59.5% in the fourth quarter. Cooke & Bieler LP now owns 613,134 shares of the medical equipment provider’s stock worth $48,088,000 after purchasing an additional 228,645 shares during the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.
Integer Stock Performance
ITGR stock opened at $126.35 on Friday. The firm has a market cap of $4.30 billion, a price-to-earnings ratio of 34.52, a PEG ratio of 2.40 and a beta of 0.62. The firm has a 50-day simple moving average of $117.59 and a two-hundred day simple moving average of $98.67. Integer has a one year low of $62.00 and a one year high of $126.79. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73.
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. The business had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company’s revenue was down 2.6% compared to the same quarter last year. During the same period last year, the business earned $1.55 EPS. On average, equities analysts forecast that Integer will post 6.09 EPS for the current fiscal year.
Integer Company Profile
Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.
Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.
See Also
- Five stocks we like better than Integer
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
